Actions of Vibrio vulnificus Metalloprotease on Human Plasma Proteinase‐Proteinase Inhibitor Systems: A Comparative Study of Native Protease with Its Derivative Modified by Polyethylene Glycol
暂无分享,去创建一个
[1] R. Miller,et al. Complete primary structure and biochemical properties of gilatoxin, a serine protease with kallikrein-like and angiotensin-degrading activities. , 1993, The Journal of biological chemistry.
[2] S. Miyoshi,et al. Chemical modification of Vibrio vulnificus metalloprotease with activated polyethylene glycol. , 1993, FEMS microbiology letters.
[3] J. Oliver,et al. Regulation of proteolytic activity of Vibrio vulnificus by iron-containing compounds. , 1993, Microbial pathogenesis.
[4] S. Miyoshi,et al. Activation mechanism of human Hageman factor‐plasma kallikreinkinin system by Vibrio vulnificus metalloprotease , 1992, FEBS letters.
[5] S. Miyoshi,et al. Significant role of an exocellular protease in utilization of heme by Vibrio vulnificus , 1992, Infection and immunity.
[6] S. Miyoshi,et al. Alpha-macroglobulin-like plasma inactivator for Vibrio vulnificus metalloprotease. , 1991, Journal of biochemistry.
[7] N. Nishino,et al. Pseudomonas aeruginosa alkaline proteinase might share a biological function with plasmin. , 1991, Biochimica et biophysica acta.
[8] H. Shon,et al. Vibrio vulnificus septicemia in Korea: clinical and epidemiologic findings in seventy patients. , 1991, Journal of the American Academy of Dermatology.
[9] C. Hack,et al. Quantification of Functional and Inactivated α2-Macroglobulin in Sepsis , 1991, Thrombosis and Haemostasis.
[10] S. Miyoshi,et al. Inhibitory effect of α2-macroglobulin on Vibrio vulnificus protease , 1989 .
[11] L. Sottrup-jensen. Alpha-macroglobulins: structure, shape, and mechanism of proteinase complex formation. , 1989, The Journal of biological chemistry.
[12] H. Maeda,et al. Activation of hageman factor and prekallikrein and generation of kinin by various microbial proteinases. , 1989, The Journal of biological chemistry.
[13] H. Maeda,et al. Inactivation of various proteinase inhibitors and the complement system in human plasma by the 56-kilodalton proteinase from Serratia marcescens , 1989, Infection and immunity.
[14] S. Moestrup,et al. Characterization, size estimation and solubilization of alpha-macroglobulin complex receptors in liver membranes. , 1989, Biochimica et biophysica acta.
[15] S. Miyoshi,et al. Role of the Protease in the Permeability Enhancement by Vibrio vulnificus , 1988, Microbiology and immunology.
[16] R. Howard,et al. Soft-tissue infections caused by halophilic marine vibrios. , 1988, Archives of surgery.
[17] H. Maeda,et al. Internalization of serratial protease into cells as an enzyme-inhibitor complex with alpha 2-macroglobulin and regeneration of protease activity and cytotoxicity. , 1987, The Journal of biological chemistry.
[18] F. Martínez-Brotons,et al. Plasma Kallikrein-Kinin System in Patients with Uncomplicated Sepsis and Septic Shock-Comparison with Cardiogenic Shock , 1987, Thrombosis and Haemostasis.
[19] S. Miyoshi,et al. Activation of the plasma kallikrein-kinin system by Vibrio vulnificus protease , 1987, Infection and immunity.
[20] M. Silverberg,et al. The coagulation-kinin pathway of human plasma , 1987 .
[21] S. Shinoda,et al. Inhibitory Effect of Capsular Antigen of Vibrio vulnificus on Bactericidal Activity of Human Serum , 1987, Microbiology and immunology.
[22] S. Miyoshi,et al. Purification and Characterization of Vibrio vulnificus Protease , 1987, Microbiology and immunology.
[23] S. Miyoshi,et al. Histamine release from rat mast cells by Vibrio vulnificus protease , 1986 .
[24] M. Kothary,et al. Production and partial characterization of an elastolytic protease of Vibrio vulnificus , 1985, Infection and immunity.
[25] P. Taylor. Bactericidal and bacteriolytic activity of serum against gram-negative bacteria. , 1983, Microbiological reviews.
[26] J. Travis,et al. Inactivation of human plasma alpha 1-proteinase inhibitor by a metalloproteinase from Serratia marcescens. , 1982, Biochimica et biophysica acta.
[27] W. Schleuning,et al. Isolation and characterization of urokinase from human plasma. , 1982, The Journal of biological chemistry.
[28] M. Hoylaerts,et al. Fibrinolytic properties of one-chain and two-chain human extrinsic (tissue-type) plasminogen activator. , 1982, The Journal of biological chemistry.
[29] S. Pizzo,et al. Clearance and binding of two electrophoretic "fast" forms of human alpha 2-macroglobulin. , 1981, The Journal of biological chemistry.
[30] S. Iwanaga,et al. New fluorogenic peptide substrates for plasmin. , 1980, Journal of biochemistry.
[31] S. Iwanaga,et al. A new fluorogenic substrate method for the estimation of kallikrein in urine. , 1980, Journal of biochemistry.
[32] J. Howard,et al. Structural characterization of human alpha2-macroglobulin subunits. , 1979, The Journal of biological chemistry.
[33] H. Tsuzuki,et al. Protease and elastase of Pseudomonas aeruginosa: inactivation of human plasma alpha 1-proteinase inhibitor , 1979, Infection and immunity.
[34] P. Blake,et al. Disease caused by a marine Vibrio. Clinical characteristics and epidemiology. , 1979, The New England journal of medicine.
[35] Tetsuo Takahashi,et al. Synthesis of a Key Fluorogenic Amide, L-Arginine-4-methylcoumaryl-7-amide (L-Arg-MCA) and Its Derivatives. Fluorescence Assays for Trypsin and Papain , 1977 .
[36] S. Iwanaga,et al. New Fluorogenic Substrates for α-Thrombin, Factor Xa, Kallikreins, and Urokinase , 1977 .
[37] K. Miller,et al. Elastase of Pseudomonas aeruginosa: Inactivation of Complement Components and Complement-Derived Chemotactic and Phagocytic Factors , 1974, Infection and immunity.
[38] U. K. Laemmli,et al. Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.
[39] R. Colman,et al. Interaction of plasma kallikrein with the C1 inhibitor. , 1970, Journal of immunology.
[40] E. Cliffton,et al. The determination of plasma fibrinogen by turbidity with ammonium sulfate. , 1953, Archives of biochemistry and biophysics.
[41] H. Maeda,et al. Different binding kinetics of Serratia 56K protease with plasma alpha 2-macroglobulin and chicken egg white ovomacroglobulin. , 1987, Journal of biochemistry.
[42] S. Miyoshi,et al. Enhancement of vascular permeability due to histamine-releasing effect of Vibrio vulnificus protease in rat skin , 1987 .
[43] M. Silverberg,et al. The coagulation-kinin pathway of human plasma. , 1987, Blood.
[44] G. Salvesen,et al. Human plasma proteinase inhibitors. , 1983, Annual review of biochemistry.
[45] A. Barrett. [54] α2-Macroglobulin , 1981 .
[46] J. Travis,et al. [55] Human α1-proteinase inhibitor , 1981 .